Poly Medicure Ltd Share Price
As on 10 June 2026 at 23:33 IST
Poly Medicure Q1 FY26 Results:
Net profit after tax declined by 72.5% to ₹93.08 crores in Q1 FY26, compared to ₹338.5 crores in Q1 FY25. Total income from operations for the quarter decreased by 4.5% year-on-year to ₹426 crores, down from ₹445 crores.
About Poly Medicure Ltd
Poly Medicure Ltd (POLYMED) is a leading Indian company specializing in the manufacturing and sale of medical devices. The company is dedicated to providing high-quality healthcare solutions. Operating in the healthcare sector, Polymed was incorporated on March 30, 1995, making it many years old. Its headquarters is located in the city of New Delhi, India. The company’s main products encompass a wide range of medical devices, including IV cannulas, catheters, and dialysis products. These offerings are designed to meet the needs of various medical specialities and are used in hospitals. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-11.63%
Over 6 Months
-23.60%
Over 1 Year
-35.85%
Over 3 Years
47.82%
Poly Medicure Ltd Summary
Close ₹1,458.80
Open ₹1,389.90
High ₹1,467
Low ₹1,389.90
Volume 3,00,893
Net Turnover (in Cr) ₹43
52Wk High ₹2,316.60
52Wk Low ₹1,182
52Wk High / Low
1,182
2,316.60
Poly Medicure Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹14,786.32
EPS (TTM) 33.65
Book Value (BV) 301.18
Div. Yield -
P/E (TTM) 43.96
Price/Book Value 4.84
Delivery % 60.71 %
Face Value 5
Key Ratios
PE Ratio 68.57
PB Ratio 8.28
EV to Sales 14.20
PEG Ratio 2.78
ROA 11.32
ROE 15.77
Debt-Equity 0.08
Net Profit Margin 20.68
Operating Profit Margin 33.54
Poly Medicure Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,758.96 | 1,434.54 | 1,151.42 | 960.97 | 804.88 |
| Total Expenses | 1,311.62 | 1,092.80 | 915.85 | 768.17 | 628.14 |
| Profit Before Tax | 452.52 | 344.27 | 237.49 | 195.24 | 180.05 |
| Profit After Tax | 338.56 | 258.26 | 179.28 | 146.51 | 135.87 |
| Operating Profit After Depreciation | 459.33 | 353.04 | 244.40 | 197.05 | 185.26 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,095.74 | 875.81 | 639.92 | 490.49 | 427.68 |
| Total Non Current Assets | 1,275.46 | 1,017.07 | 770.20 | 593.40 | 519.62 |
| Total Current Assets | 1,917 | 841.60 | 807.01 | 783.44 | 704.11 |
| Total Assets | 3,192.45 | 1,858.67 | 1,577.21 | 1,376.83 | 1,223.73 |
| Total Shareholder's Fund | 2,765.66 | 1,470.05 | 1,241.63 | 1,087.48 | 965.57 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 240.42 | 266.08 | 190.83 | 123.47 | 118.73 |
| Net Cash Used In Investing Activities | -1,194.28 | -240.94 | -179.02 | -85.33 | -435.58 |
| Net Cash Used In Financing Activities | 950.51 | -20.15 | -12.51 | -35.34 | 316.95 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,691.57 | 1,365.43 | 1,104.33 | 918.09 | 766.67 |
| Total Expenses | 1,248.68 | 1,030.53 | 867.51 | 723.37 | 593.29 |
| Profit Before Tax | 442.89 | 334.89 | 236.83 | 194.72 | 173.38 |
| Profit After Tax | 331.33 | 251.72 | 179.04 | 146.02 | 129.51 |
| Operating Profit After Depreciation | 454.30 | 345.63 | 245.13 | 198.32 | 181.29 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,050.67 | 834.86 | 602.64 | 453.32 | 391.40 |
| Total Non Current Assets | 1,280.02 | 1,029.57 | 782.49 | 592.97 | 512.06 |
| Total Current Assets | 1,860.34 | 791.78 | 755.27 | 740.99 | 675.35 |
| Total Assets | 3,140.36 | 1,821.35 | 1,537.76 | 1,333.96 | 1,187.41 |
| Total Shareholder's Fund | 2,744.22 | 1,458.25 | 1,234.12 | 1,076.97 | 954.01 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 236.65 | 256.10 | 196.83 | 126.26 | 116.40 |
| Net Cash Used In Investing Activities | -1,191.17 | -237.02 | -189.18 | -88.71 | -434.41 |
| Net Cash Used In Financing Activities | 952.93 | -17.32 | -7.89 | -39.71 | 318.92 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 534.51 | 493.66 | 443.88 | 403.21 | 440.83 |
| Total Expenses | 424.12 | 382.47 | 329.20 | 297.50 | 321.37 |
| Profit Before Tax | 85.22 | 97.62 | 121.68 | 122.94 | 122.85 |
| Profit After Tax | 65.04 | 70.81 | 91.80 | 93.08 | 91.83 |
| Operating Profit after Depreciation | 129.86 | 139.14 | 149.58 | 149.15 | 146.05 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 443.01 | 418.86 | 416.54 | 384.05 | 420.97 |
| Total Expenses | 321.93 | 306.59 | 305.32 | 282.85 | 304.93 |
| Profit Before Tax | 106.80 | 106.02 | 118.01 | 117.07 | 116.49 |
| Profit After Tax | 80.62 | 78.38 | 89.05 | 87.93 | 86.66 |
| Operating Profit after Depreciation | 136.20 | 141.82 | 144.94 | 142.72 | 139.99 |
Poly Medicure Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 1,410.13
S2 1,361.47
S3 1,333.03
Pivot 1,438.57
R1 1,487.23
R2 1,515.67
R3 1,564.33
Moving Average
20 SMA 1,456.61
50 SMA 1,456.43
100 SMA 1,436.04
200 SMA 1,678.41
Poly Medicure Ltd Corporate Actions
Poly Medicure Ltd
₹3.5/Share
Announcement Date 18 Sep 2025
Record Date 18 Sep 2025
Div Yield 70%
Poly Medicure Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,525.60 | ₹1,22,585.05 |
| Max Healthcare Institute Ltd | ₹1,003.25 | ₹97,640.68 |
| Fortis Healthcare Ltd | ₹990.40 | ₹74,771.05 |
| Aster DM Healthcare Ltd | ₹790.25 | ₹40,944.51 |
| Narayana Hrudayalaya Ltd | ₹1,932.30 | ₹39,488.64 |
Poly Medicure Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Quant Small Cap Fund | 2.17% |
| SBI Healthcare Opportunities Fund | 1.89% |
| Invesco India Largecap Fund | 1.52% |
| SBI MNC Fund | 1.25% |
| UTI-Flexi Cap Fund | 0.85% |
Poly Medicure Ltd News
Poly Medicure appoints CEO - Asia Pacific and India Business
01 Jun 2026, 07:02 pm
Board of Poly Medicure recommends final dividend
Of Rs 3.5 per share
25 May 2026, 06:42 pm
Poly Medicure ends lower after Q4 PAT slumps 29% YoY to Rs 65 cr
Poly Medicure declined 3.78% to end at Rs 1,538.35 after the company's consolidated net profit dropped 29.17% to Rs 65.04 crore despite 21.25% jump in revenue from operations to Rs 534.51 crore in Q4 FY26 over Q4 FY25.
25 May 2026, 05:20 pm
Poly Medicure to announce Quarterly Result
On 25 May 2026
15 May 2026, 05:43 pm
Poly Medicure to convene board meeting
On 5 February 2026
30 Jan 2026, 10:53 am
Poly Medicure Ltd Stock Analysis
- Annual revenue for Poly Medicure Ltd increased by 23.89% to ₹1,691.57 crore in FY 2025 from ₹1,365.43 crore in FY 2024.
- Annual Net Profit for Poly Medicure Ltd increased by 31.63% to ₹331.33 crore in FY 2025 from ₹251.72 crore in FY 2024.
- Promoter Shareholding in Poly Medicure Ltd remains unchanged by 0.00% in the most recent quarter, from 62.42% in December 2025 to 62.42% in March 2026.
- Poly Medicure Ltd delivered a 1-year return of -35.85% compared to the Nifty 50, which provided a return of -7.41% as of the last trading session.
- Poly Medicure Ltd share price moved down by 1.12% from its previous close of INR ₹1,458.80. The latest Poly Medicure Ltd share price is INR ₹1,442.40.
- Poly Medicure Ltd share price today has been at a low of 1,425.20 and a high of 1,470. Over the past 52 weeks, the Poly Medicure Ltd share price has seen a low of 1,182 and a high of 2,316.60.
About Poly Medicure Ltd
Poly Medicure Ltd is a leading Indian company specializing in the manufacturing and sale of medical devices. The company is dedicated to providing high-quality healthcare solutions. It has a diverse product portfolio that includes infusion therapy and dialysis products.
Poly Medicure Ltd operates in the healthcare sector. It specializes in the medical equipment and supplies industry. The company was incorporated on March 30, 1995. Its headquarters is located in New Delhi, India.
The promoters of the company include Ezekiel Global Business Solutions LLP, with a 12.20% stake. The company has managerial promoters who manage the operations of the company. They are -
As of the latest data, Poly Medicure Ltd is not the number one stock in its sector, but it is a significant player with a strong market presence. The company has a market capitalization of approximately ₹27,680 crore as of 2024.
The registered office, as well as the office of the registrars of Poly Medicure Ltd, is in Okhla Industrial Estate, New Delhi. Poly Medicure Ltd continues to innovate and expand its product range. It maintains a strong focus on quality and customer satisfaction. The company has a strong portfolio and a commitment to excellence. This positions it well for continued growth in the healthcare industry.
The vision of Poly Medicure Ltd is rooted in a deep commitment to excellence. The company strives to be a global leader in the medical devices industry. It focuses on delivering products that meet the highest standards of quality and safety. This commitment is evident in every aspect of the company's operations. It spans research and development, manufacturing, and customer service.
Innovation is at the heart of Poly Medicure Ltd's vision. The company invests significantly in research and development. It focuses on creating cutting-edge medical devices that enhance patient outcomes. This focus on innovation keeps Polymed at the forefront of the medical devices industry. The company continually introduces new products that meet the evolving needs of healthcare providers and patients.
Sustainability is another key component of Poly Medicure Ltd's vision. The company understands the importance of environmental stewardship. It is dedicated to minimizing its environmental impact. This commitment is reflected in the company's efforts to reduce waste and promote sustainable practices across its operations. Polymed's sustainability initiatives aim to ensure the company can continue providing high-quality healthcare products. At the same time, they focus on protecting the planet for future generations.
Poly Medicure Ltd's vision also emphasizes the importance of customer satisfaction. The company strives to exceed customer expectations by delivering high-quality products. These products are also reliable and easy to use. This customer-centric approach has helped Polymed build strong relationships with healthcare providers and patients around the world.
The company's vision extends beyond its products and services to include its corporate culture. Poly Medicure Ltd is committed to fostering a positive and inclusive work environment where employees are encouraged to innovate and excel. The company believes that a motivated and engaged workforce is key to achieving its vision. This vision is to provide the highest quality healthcare.
Poly Medicure Ltd's vision is also reflected in its commitment to social responsibility. The company is dedicated to making a positive impact on the communities it serves. This commitment is demonstrated through various corporate social responsibility initiatives. These include efforts to improve access to healthcare in underserved areas and support for educational and community development programs.
The vision of Poly Medicure Ltd is not just about what the company does but also how it does it. The company is committed to conducting its business with integrity and transparency. This commitment to ethical business practices is a cornerstone of Polymed's vision and is essential to building trust with customers and stakeholders.
Poly Medicure Ltd's vision is ambitious, and it is well-positioned to achieve it. With a strong foundation of innovation and social responsibility, Polymed is poised to continue its growth and make a lasting impact on the healthcare industry. The company's vision serves as a guiding light. It inspires employees to strive for excellence and make a difference in the lives of people around the world.
Poly Medicure Ltd operates in the healthcare sector. It specializes in the medical equipment and supplies industry. The company was incorporated on March 30, 1995. Its headquarters is located in New Delhi, India.
The promoters of the company include Ezekiel Global Business Solutions LLP, with a 12.20% stake. The company has managerial promoters who manage the operations of the company. They are -
- Devendra Raj Mehta
- Himanshu Baid
- Rishi Baid
- Jugal Kishore Baid
- Mukulika Baid
As of the latest data, Poly Medicure Ltd is not the number one stock in its sector, but it is a significant player with a strong market presence. The company has a market capitalization of approximately ₹27,680 crore as of 2024.
The registered office, as well as the office of the registrars of Poly Medicure Ltd, is in Okhla Industrial Estate, New Delhi. Poly Medicure Ltd continues to innovate and expand its product range. It maintains a strong focus on quality and customer satisfaction. The company has a strong portfolio and a commitment to excellence. This positions it well for continued growth in the healthcare industry.
The vision of Poly Medicure Limited
Poly Medicure Ltd, often known as Polymed, is a company driven by a clear and compelling vision. This vision centres on providing the highest quality healthcare to people around the world. The company believes that access to quality healthcare is a fundamental right, and it strives to make this a reality through its innovative products and services.The vision of Poly Medicure Ltd is rooted in a deep commitment to excellence. The company strives to be a global leader in the medical devices industry. It focuses on delivering products that meet the highest standards of quality and safety. This commitment is evident in every aspect of the company's operations. It spans research and development, manufacturing, and customer service.
Innovation is at the heart of Poly Medicure Ltd's vision. The company invests significantly in research and development. It focuses on creating cutting-edge medical devices that enhance patient outcomes. This focus on innovation keeps Polymed at the forefront of the medical devices industry. The company continually introduces new products that meet the evolving needs of healthcare providers and patients.
Sustainability is another key component of Poly Medicure Ltd's vision. The company understands the importance of environmental stewardship. It is dedicated to minimizing its environmental impact. This commitment is reflected in the company's efforts to reduce waste and promote sustainable practices across its operations. Polymed's sustainability initiatives aim to ensure the company can continue providing high-quality healthcare products. At the same time, they focus on protecting the planet for future generations.
Poly Medicure Ltd's vision also emphasizes the importance of customer satisfaction. The company strives to exceed customer expectations by delivering high-quality products. These products are also reliable and easy to use. This customer-centric approach has helped Polymed build strong relationships with healthcare providers and patients around the world.
The company's vision extends beyond its products and services to include its corporate culture. Poly Medicure Ltd is committed to fostering a positive and inclusive work environment where employees are encouraged to innovate and excel. The company believes that a motivated and engaged workforce is key to achieving its vision. This vision is to provide the highest quality healthcare.
Poly Medicure Ltd's vision is also reflected in its commitment to social responsibility. The company is dedicated to making a positive impact on the communities it serves. This commitment is demonstrated through various corporate social responsibility initiatives. These include efforts to improve access to healthcare in underserved areas and support for educational and community development programs.
The vision of Poly Medicure Ltd is not just about what the company does but also how it does it. The company is committed to conducting its business with integrity and transparency. This commitment to ethical business practices is a cornerstone of Polymed's vision and is essential to building trust with customers and stakeholders.
Poly Medicure Ltd's vision is ambitious, and it is well-positioned to achieve it. With a strong foundation of innovation and social responsibility, Polymed is poised to continue its growth and make a lasting impact on the healthcare industry. The company's vision serves as a guiding light. It inspires employees to strive for excellence and make a difference in the lives of people around the world.
FAQ’s
What is the share price of Poly Medicure Ltd today?
Poly Medicure Ltd share price as on 10 Jun 2026 is ₹ 1442.4
What is the Market Cap of Poly Medicure Ltd?
The market cap of Poly Medicure Ltd stock is ₹14,786.32 Cr.
What is the PE Ratio of Poly Medicure Ltd?
The Price to Earnings (P/E) Ratio of Poly Medicure Ltd is 68.57
What is the PB Ratio of Poly Medicure Ltd?
The Price to Book (P/B) Ratio of Poly Medicure Ltd is 8.28
What is the 52 week high of Poly Medicure Ltd Share Price?
The 52 week high of Poly Medicure Ltd share price stands at ₹2,316.60
What is the 52 week low of Poly Medicure Ltd Share Price?
The 52 week low of Poly Medicure Ltd share price stands at ₹1,182
How can I buy shares of Poly Medicure Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Poly Medicure Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
